Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Health Canada approves Strensiq for hypophosphatasia

Aug. 18, 2015

PhytoTech Medical completes acquisition of MMJ Bioscience

July 31, 2015

Health Canada clears Hydra to begin phase I study of HX-100

April 16, 2015

Novartis's LCZ-696 awarded priority review by Health Canada

March 13, 2015

PBI-4050 granted U.S. orphan drug status for IPF

Feb. 18, 2015

Health Canada updates Zelboraf labeling to advise of pancreatitis risk

Feb. 13, 2015

ProMetic receives clearance to start trial of PBI-4050 in metabolic-syndrome-associated diabetes

Jan. 29, 2015

Tekmira authorized to start phase I trial of RNAi therapeutic for HBV infection

Dec. 29, 2014

Health Canada clears Immunovaccine to conduct phase II trial of DPX-Survivac

Nov. 20, 2014

PBI-4050 cleared to commence trials in patients with diabetic kidney disease

Nov. 12, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...